MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis

News Healthcare & Pharma Law & Policy Updates

Date: 15th May, 2025 Source: Medicines and Healthcare products Regulatory Agency (MHRA) Country: United Kingdom Original Source

Brief

On 15/05/2025, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an update regarding MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis. The Capvaxive vaccine is approved for people aged 18 years and older to help protect against illnesses caused by Streptococcus pneumoniae bacteria.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis

Brief

Medicines and Healthcare products Regulatory Agency (MHRA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis

Brief

Medicines and Healthcare products Regulatory Agency (MHRA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.